Caligan Partners »

Vaxcyte shares owned by Caligan Partners

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Caligan Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $79M 1.7M 46.14

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Exelixis (EXEL)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Inhibrx Biosciences (INBX)
Tango Therapeutics (TNGX)
Tyra Biosciences (TYRA)
Maze Therapeatics (MAZE)
Rapt Therapeutics Com New (RAPT)
Avalo Therapeutics Com New (AVTX)
Anika Therapeutics (ANIK)

View all positions for Caligan Partners

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Westfield Capital Management Company
Kynam Capital Management
Deep Track Capital
Geode Capital Management
Caligan Partners

View all funds holding Vaxcyte